Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Phreesia (PHR) EBITDA (2018 - 2025)

Phreesia's EBITDA history spans 8 years, with the latest figure at $6.9 million for Q4 2025.

  • For Q4 2025, EBITDA rose 167.51% year-over-year to $6.9 million; the TTM value through Oct 2025 reached $4.0 million, up 106.13%, while the annual FY2025 figure was -$43.9 million, 63.06% up from the prior year.
  • EBITDA for Q4 2025 was $6.9 million at Phreesia, up from $1.8 million in the prior quarter.
  • Across five years, EBITDA topped out at $6.9 million in Q4 2025 and bottomed at -$46.3 million in Q2 2022.
  • The 5-year median for EBITDA is -$22.7 million (2021), against an average of -$21.0 million.
  • The largest annual shift saw EBITDA tumbled 773.22% in 2021 before it skyrocketed 167.51% in 2025.
  • A 5-year view of EBITDA shows it stood at -$32.0 million in 2021, then fell by 9.13% to -$34.9 million in 2022, then increased by 21.13% to -$27.6 million in 2023, then skyrocketed by 62.71% to -$10.3 million in 2024, then surged by 167.51% to $6.9 million in 2025.
  • Per Business Quant, the three most recent readings for PHR's EBITDA are $6.9 million (Q4 2025), $1.8 million (Q3 2025), and -$301000.0 (Q2 2025).